"Rosacea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
| Descriptor ID |
D012393
|
| MeSH Number(s) |
C17.800.716
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Rosacea".
Below are MeSH descriptors whose meaning is more specific than "Rosacea".
This graph shows the total number of publications written about "Rosacea" by people in this website by year, and whether "Rosacea" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rosacea" by people in Profiles.
-
Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement. JAMA Dermatol. 2024 Jun 01; 160(6):658-666.
-
Azithromycin as an alternative rosacea therapy when tetracyclines prove problematic. J Drugs Dermatol. 2008 Sep; 7(9):898-9.
-
The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis. 2007 Jan; 79(1):73-80.
-
Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. Cutis. 2006 Apr; 77(4 Suppl):3-11.
-
Glycomics analyses of tear fluid for the diagnostic detection of ocular rosacea. J Proteome Res. 2005 Nov-Dec; 4(6):1981-7.
-
Present and future rosacea therapy. Cutis. 2005 Mar; 75(3 Suppl):4-7; discussion 33-6.
-
The treatment of rosacea. Cutis. 2004 Jan; 73(1 Suppl):34-6.
-
The role of topical metronidazole in the treatment of rosacea. Cutis. 2004 Jan; 73(1 Suppl):19-28.
-
Pseudokeratoconus caused by rosacea. Cornea. 2001 Aug; 20(6):668-9.
-
Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci. 2000 Jun; 41(7):1703-9.